{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T02:22:39Z","timestamp":1782354159140,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.endonu.2013.03.008","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T10:45:22Z","timestamp":1372934722000},"page":"52-61","source":"Crossref","is-referenced-by-count":17,"title":["Pron\u00f3stico del paciente tratado de s\u00edndrome de Cushing"],"prefix":"10.1016","volume":"61","author":[{"given":"Anna","family":"Aulinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Valassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2013.03.008_bib0005","first-page":"75","article-title":"Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome","volume":"22","author":"Lacroix","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.endonu.2013.03.008_bib0010","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1590\/S0004-27302007000800025","article-title":"Cushing's syndrome: Aftermath of the cure","volume":"51","author":"Pivonello","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11102-012-0394-8","article-title":"Clinical consequences of Cushing's syndrome","volume":"15","author":"Valassi","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.endonu.2013.03.008_bib0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-11-1095","article-title":"The burden of Cushing's disease: Clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0030","first-page":"2664","article-title":"Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure","volume":"84","author":"Colao","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0035","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2012-3547","article-title":"Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing's syndrome","volume":"98","author":"Barahona","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","article-title":"Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission","volume":"75","author":"Giordano","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endonu.2013.03.008_bib0045","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1210\/jc.2011-3123","article-title":"Body composition and cardiovascular risk markers after remission of Cushing's disease: A prospective study using whole-body MRI","volume":"97","author":"Geer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0050","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000330416","article-title":"Adipokines and cardiovascular risk in Cushing's syndrome","volume":"95","author":"Valassi","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.endonu.2013.03.008_bib0060","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2337\/diabetes.52.6.1409","article-title":"Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob\/ob mice","volume":"52","author":"Liu","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.endonu.2013.03.008_bib0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2008.01.012","article-title":"Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene","volume":"26","author":"Iwasaki","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0070","first-page":"2747","article-title":"Plasma leptin levels do not change in patients with Cushing's disease shortly after correction of hypercortisolism","volume":"82","author":"Cizza","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0075","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jc.2009-0806","article-title":"Metabolic, cardiovasculars and cerebrovascular outcomes in growth-hormone deficient subjects with previous Cushing's disease or non-functioning pituitary adenoma","volume":"95","author":"Webb","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0080","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-09-0836","article-title":"Clinical Features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease","volume":"162","author":"H\u00f6ybye","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2265.2004.02018.x","article-title":"Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease","volume":"60","author":"Johannsson","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endonu.2013.03.008_bib0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: An epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endonu.2013.03.008_bib0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000318566","article-title":"Cardiovascular disease in Cushing's syndrome: Heart versus vasculature","volume":"92","author":"De Leo","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.endonu.2013.03.008_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/EJE-11-0601","article-title":"Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome","volume":"166","author":"Yiu","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-09-0621","article-title":"Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome","volume":"162","author":"Pereira","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2011.04206.x","article-title":"Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure","volume":"76","author":"Toja","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endonu.2013.03.008_bib0115","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0120","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with Cushing's syndrome: A multicenter cohort study","volume":"96","author":"Stuijver","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0125","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","article-title":"Hypercoagulable state in Cushing's syndrome: A systematic review","volume":"94","author":"Van Zanne","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-10-0583","article-title":"Changes in coagulation indexes and ocurrence of venous thromboembolism in patients with Cushing's syndrome: Results from a prospective study before and after surgery","volume":"163","author":"Manetti","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/BF03344133","article-title":"Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications","volume":"29","author":"Tsagarakis","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.endonu.2013.03.008_bib0140","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/hr.2011.90","article-title":"Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment","volume":"34","author":"Akaza","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.endonu.2013.03.008_bib0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1507\/endocrj.K07E-177","article-title":"Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome","volume":"55","author":"Tsuiki","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.endonu.2013.03.008_bib0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/eje.0.1450241","article-title":"Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity inpatients with endogenous glucocorticoid excess due to adrenal mass","volume":"145","author":"Tauchmanov\u00e0","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0155","first-page":"362","article-title":"Coxarthrosis secondary to ischemic necrosis of the femoral head in Cushing's disease","volume":"77","author":"Kobayashi","year":"1991","journal-title":"Rev Chir Orthop Reparatrice Appar Mot"},{"key":"10.1016\/j.endonu.2013.03.008_bib0160","first-page":"3010","article-title":"Cushing's disease presenting with avascular necrosis of the hip: An orthopedic emergency","volume":"84","author":"Koch","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11845-011-0717-1","article-title":"Avascular necrosis of femoral heads post-adrenal surgery for Cushing's syndrome: A rare presentation","volume":"181","author":"Saeed","year":"2012","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.endonu.2013.03.008_bib0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000314298","article-title":"Skeletal diseases in Cushing's syndrome: Osteoporosis versus arthropathy","volume":"92","author":"Kaltsas","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.endonu.2013.03.008_bib0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-09-0800","article-title":"Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome","volume":"162","author":"Camozzi","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0180","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1210\/jc.2006-2283","article-title":"Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile","volume":"92","author":"Dovio","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0185","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.C000290200","article-title":"Osteoprotegerin is an a \u03b23-induced, NF-kB-dependent survival factor for endothelian cells","volume":"275","author":"Malyankar","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.endonu.2013.03.008_bib0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/eje.1.02067","article-title":"Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: A prospective, long-term study","volume":"154","author":"Kristo","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0195","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1359\/jbmr.090505","article-title":"Deleterious effects of glucocorticoids replacement on bone in women after long-term remission of Cushing's syndrome","volume":"24","author":"Barahona","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.endonu.2013.03.008_bib0200","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2265.2003.01713.x","article-title":"Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: A prospective study","volume":"58","author":"Di Somma","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endonu.2013.03.008_bib0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2265.1992.tb01437.x","article-title":"Normal bone density following cure of Cushing's syndrome","volume":"36","author":"Manning","year":"1992","journal-title":"Clin Endocirnol (Oxf)"},{"key":"10.1016\/j.endonu.2013.03.008_bib0210","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11102-005-1051-2","article-title":"Cushing's syndrome and bone","volume":"7","author":"Mancini","year":"2004","journal-title":"Pituitary"},{"key":"10.1016\/j.endonu.2013.03.008_bib0215","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1210\/jc.2002-021494","article-title":"Nephrolithiasis in Cushing's disease: Prevalence, etiopathogenesis, and modification after disease cure","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0220","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF03343978","article-title":"Evaluation of circulating levels and renal clearance of natural aminoacids in patients with Cushing's disease","volume":"25","author":"Faggiano","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.endonu.2013.03.008_bib0225","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2007-1014405","article-title":"Psychiatric phenomenology in Cushing's disease","volume":"25","author":"Loosen","year":"1992","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.endonu.2013.03.008_bib0230","first-page":"1949","article-title":"Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism","volume":"87","author":"Bourdeau","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.endonu.2013.03.008_bib0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000314317","article-title":"Neuropshychiatric disorders in Cushing's syndrome","volume":"92","author":"Pereira","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.endonu.2013.03.008_bib0240","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1210\/jc.2011-2231","article-title":"Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome","volume":"97","author":"Resmini","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0245","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","article-title":"Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome","volume":"32","author":"Starkman","year":"1992","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.endonu.2013.03.008_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2009-2032","article-title":"Subtle cognitive impairment in patients with long-term cure of Cushing's disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0924-977X(95)00039-R","article-title":"The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression","volume":"1","author":"Stokes","year":"1995","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0260","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2010-0512","article-title":"Increased prevalence of psychopathology and maladaptative personality traits after long-term cure of Cushing's disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0265","first-page":"912","article-title":"The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism","volume":"82","author":"Dorn","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0270","doi-asserted-by":"crossref","first-page":"E1670","DOI":"10.1210\/jc.2011-1317","article-title":"Overt immune dysfunction after Cushing's syndrome remission: A consecutive case series and review of the literature","volume":"96","author":"Da Mota","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2265.2000.01018.x","article-title":"Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease","volume":"53","author":"Coalo","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endonu.2013.03.008_bib0280","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","article-title":"Quality of life in patients after long-term biochemical cure of Cushing's disease","volume":"90","author":"Van Aken","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0285","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2265.2008.03288.x","article-title":"Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas","volume":"69","author":"Van der Klaaw","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endonu.2013.03.008_bib0290","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0762","article-title":"Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire","volume":"158","author":"Webb","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0295","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/EJE-12-0325","article-title":"Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice","volume":"167","author":"Santos","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0300","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1460067","article-title":"Growth hormone deficiency and replacement in hypopituitary pateitns previously treated for acromegaly or Cushing's disease","volume":"146","author":"Feldt-Rasmussen","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endonu.2013.03.008_bib0305","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2796.1999.00483.x","article-title":"The survival and well-being of patients treated for Cushing's syndrome","volume":"245","author":"Pikkarainen","year":"1999","journal-title":"J Intern Med"},{"key":"10.1016\/j.endonu.2013.03.008_bib0310","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9343(52)90027-2","article-title":"The natural history of Cushing's disease","volume":"13","author":"Plotz","year":"1952","journal-title":"Am J Med"},{"key":"10.1016\/j.endonu.2013.03.008_bib0315","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.endonu.2013.03.008_bib0320","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000315813","article-title":"Mortality in Cushing's disease","volume":"92","author":"Clayton","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.endonu.2013.03.008_bib0325","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing's syndrome: A systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.endonu.2013.03.008_bib0330","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing's disease: Initial outcomes and longterm results","volume":"89","author":"Hammer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2013.03.008_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: Audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092213001381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092213001381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T15:37:37Z","timestamp":1584027457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092213001381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1575092213001381"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2013.03.008","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}